10.01.2013
- Bayer MaterialScience, a subgroup of the Bayer Group and world leading materials provider, has officially opened its first Polymer Development & Technology Center in South Korea...
03.01.2013
- Rare diseases are a growing focus for drug companies, with prices for some treatments for ultra-rare conditions running into hundreds of thousands of dollars a year. The following...
03.01.2013
- The Western world's first drug to fix faulty genes promises to transform the lives of patients with an ultra-rare disease that clogs their blood with fat. The only snag is the...
02.01.2013
- U.S. regulators approved 39 new drugs in 2012, the most in 16 years, suggesting that pharmaceutical makers are poised for growth after losing billions of dollars in recent years to...
19.12.2012
- The number of new medicines approved or pending approval is on the rise on both sides of the Atlantic, painting an encouraging picture for the global drugs industry as it emerges...
18.12.2012
- Aesica, the global contract manufacturing organisation (CMO), announces its second major innovation board partnership following the recent annual Genesis conference, a famed hotbed...
04.12.2012
- Drug companies are becoming more efficient in hunting for new treatments, though this has yet to be reflected in improved investment returns, according to a report on Tuesday. Low...
03.12.2012
- Success Factors - With numerous new products, the Bayer Group aims to help improve people's lives while exploiting billions in potential sales. "Innovation is the only way to...
